H.E.F. Inc. Box 651 • Scarsdale, NY 10583 FREE CME COURSES Update on the Management of Hypertension October 24, 2007 Sheraton Los Angeles Downtown, Los Angeles, CA Credits: 3.5 Update on the Management of Hypertension September 26, 2007 Mission Bay Conference Center at UCSF, San Francisco, CA Credits: 3.5 RELATED LINKS Get the FREE Adobe Reader: Site Maintained by: Le Jacq     he following articles have recently been published in The Journal of Clinical Hypertension®. Downloads are available in Adobe Acrobat format: ORIGINAL PAPER Hypertension Management: Results of a New National Survey for the Hypertension Education Foundation: Harris Interactive Marvin Moser, MD; Stanley S. Franklin, MD- J Clin Hypertens(2007) 9;5:316–323 EDITORIALS Ten Years and Counting: The Journal of Clinical Hypertension Marvin Moser, MD- J Clin Hypertens(2007) 10;5:333–340 Seven Decades of Progress Marvin Moser, MD- J Clin Hypertens(2007) 9;5:310–313 Hypertension Treatment Guidelines: Is It Time for an Update? Marvin Moser, MD- J Clin Hypertens(2007) 9;1:9–14 Hypertension Treatment–A Success Study Marvin Moser, MD- J Clin Hypertens(2006) 8;5:313–314 More Confusing Messages From the Hypertension Treatment Trials Marvin Moser, MD- J Clin Hypertens(2006) 8;1:8–11 The ASCOT Trial Marvin Moser, MD- J Clin Hypertens(2005) 7;12:748–750 Comments on the Present Status and Future Directions of Postgraduate Medical Education Marvin Moser, MD- J Clin Hypertens(2005) 7;10:576–577 Comments on Progress, Medical Care, and the Overuse of Technology Marvin Moser, MD- J Clin Hypertens(2005) 7;8:442–444 Are Lifestyle Interventions in the Management of Hypertension Effective? How Long Should You Wait Before Starting Specific Medical Therapy? An Ongoing Debate Marvin Moser, MD- J Clin Hypertens(2005) 7;6:324–326 The Media, Litigation, and the COX2 Debate Marvin Moser, MD- J Clin Hypertens(2005) 7;4:202–204 ROUNDTABLE DISCUSSIONS Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers: Is There a Difference in Response and Any Advantage to Using Them Together in the Treatment of Hypertension? Marvin Moser, MD; Clive Rosendorff, MD, PhD; William B. White, MD - J Clin Hypertens(2008) 10;6:489–496 How to Treat Hypertension in Patients With Coronary Heart Disease Marvin Moser, MD; Jackson T. Wright Jr, MD, PhD; Ronald G. Victor, MD; Joel Handler, MD - J Clin Hypertens(2008) 10;5:390–397 The Treatment of Hypertension in the Elderly Marvin Moser, MD; William C. Cushman, MD; Michael G. Ziegler, MD- J Clin Hypertens(2008) 10;1:58–68 Control of Blood Pressure: Does It Matter Which Agent You Use? Marvin Moser, MD; William C. Cushman, MD; Norman M. Kaplan, MD- J Clin Hypertens(2007) 9;12:964–973 The Use of Renin Inhibitors in the Management of Hypertension Marvin Moser, MD; Joseph L. Izzo Jr, MD; Domenic A. Sica, MD- J Clin Hypertens(2007) 9;9:701–705 Microalbuminuria, Chronic Renal Disease, and the Effects of the Metabolic Syndrome on Cardiovascular Events Marvin Moser, MD; James R. Sowers, MD; Henry R. Black, MD- J Clin Hypertens(2007) 9;7:551–556 The ALLHAT Study Revisited: Do Newer Data From This Trial and Others Indicate Changes in Treatment Guidelines? Marvin Moser, MD; Suzanne Oparil, MD; William Cushman, MD; Vasilios Papademetriou, MD- J Clin Hypertens(2007) 9;5:372–380 The Nonpharmacologic Treatment of Hypertension: How Effective Is It? An Update Marvin Moser, MD; Stanley S. Frankiln, MD; Joel Handler, MD- J Clin Hypertens(2007) 9;3:209–216 Prehypertension—What Is It and Should It Be Treated? Marvin Moser, MD; Thomas D. Giles, MD; Thomas G. Pickering, MD, DPhil; Joseph L. Izzo, Jr., MD; Henry R. Black, MD- J Clin Hypertens(2006) 8;11:812–818 The ASCOT Trial—Are β-Blockers Still Useful as Antihypertensive Medication? Marvin Moser, MD; Thomas D. Giles, MD; Thomas G. Pickering, MD, DPhil; Ronald G. Victor, MD- J Clin Hypertens(2006) 8;10:723–728 Resistant or Difficult-to-Treat Hypertension Marvin Moser, MD; William Cushman, MD; Joel Handler, MD- J Clin Hypertens(2006) 8;6:434–440 Hypertensive Emergencies Marvin Moser, MD; Joseph L. Izzo, Jr., MD; John Bisognano, MD- J Clin Hypertens(2006) 8;4:275–281 Out-of-Office Blood Pressures–Are They Helpful in Guiding the Treatment of Hypertension Patients? Marvin Moser, MD; Raymond Townsend, MD; Norman Kaplan, MD- J Clin Hypertens(2006) 8;3:202–206 The Metabolic Syndrome–What Is It and How Should It Be Managed? Marvin Moser, MD; Bonita Falkner, MD; Michael A. Weber, MD; Leonard Mark Keilson, MD- J Clin Hypertens(2006) 8;1:44–49 A Conversation With Drs. Kaplan and Moser About Conflicting Data, Confusing Results, and Some Recent Treatment Recommendations for the Management of Hypertension Wendy Post, MD, MS; Marvin Moser, MD; Norman Kaplan, MD- J Clin Hypertens(2005) 7;10:606–611 Conflicting and Confusing Data From the Hypertension Treatment Trials: Whom and What Should You Believe? Marvin Moser, MD; Thomas Giles, MD; Suzanne Oparil, MD- J Clin Hypertens(2005) 7;7:403–408 The Role of β Blockers in the Management of Hypertension Marvin Moser, MD; Thomas G. Pickering, MD, DPhil; William C. Cushman, MD- J Clin Hypertens(2005) 7;5:295–299 Secondary Hypertension–Whom and How Do You Study? What Type of Therapy Is Appropriate? Marvin Moser, MD; Ronald Victor, MD; Joel Handler, MD- J Clin Hypertens(2005) 7;4:224–230 New-Onset Diabetes in Treated Hypertensive Patients–Is It Clinically Significant? Marvin Moser, MD; James R. Sowers, MD; Suzanne Oparil, MD; Henry Black, MD- J Clin Hypertens(2005) 7;2:90–95 Hypertension in Children and Adolescents Marvin Moser, MD; Thomas D. Giles, MD; Bonita Falkner, MD; Allan B. Schwartz, MD; Raymond R. Townsend, MD- J Clin Hypertens(2005) 7;1:24–30